Component
Zeaxanthin dipalmitate
Zeaxanthin dipalmitate. Species, exposure and limitations are retained in each linked claim.
10 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Zeaxanthin dipalmitate did not significantly increase ABCG5 expression in the comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- Free and esterified pigment produced different expression responses.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 704–715
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-ester-abcg5-null Zeaxanthin dipalmitate did not significantly increase ABCG5 expression in the comparison. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Free and esterified pigment produced different expression responses. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceAfter dipalmitate exposure, about 80.8% of cell-associated zeaxanthin species were free zeaxanthin.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- Most of the measured intracellular pigment was de-esterified.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 665–676
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-ester-free-product After dipalmitate exposure, about 80.8% of cell-associated zeaxanthin species were free zeaxanthin. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Most of the measured intracellular pigment was de-esterified. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceThe dipalmitate preparation produced a higher plasma-response AUC than the free preparation in this crossover trial.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/15137922.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6410a0f5d52cf32390f90f59a7b17d2340a889f888836129f8a93482ca055be0", "start_char": 0, "end_char": 1847, "text_sha256": "6410a0f5d52cf32390f90f59a7b17d2340a889f888836129f8a93482ca055be0"}
- experimental_model
- Randomized single-blind crossover meal trial
- exposure
- 5 mg free zeaxanthin equivalents as free pigment or dipalmitate in yoghurt/breakfast; 24 h sampling
- limitations
- Meal- and formulation-specific response; no proof of disease prevention or an optimal universal formulation.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- 12 volunteers
- plain_language
- Chemical form changed the measured response to this meal.
- primary_references
- [zeaxanthin-p15137922] Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography. (2004). https://pubmed.ncbi.nlm.nih.gov/15137922/ DOI: 10.1079/bjn20041105
- tissue_or_cell_type
- Plasma response
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 795–806
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized single-blind crossover meal trial · source_derived_draft · unverified_draft
### zeaxanthin-ester-human-response The dipalmitate preparation produced a higher plasma-response AUC than the free preparation in this crossover trial. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Chemical form changed the measured response to this meal. organism: 12 volunteers tissue_or_cell_type: Plasma response experimental_model: Randomized single-blind crossover meal trial limitations: Meal- and formulation-specific response; no proof of disease prevention or an optimal universal formulation. exposure: 5 mg free zeaxanthin equivalents as free pigment or dipalmitate in yoghurt/breakfast; 24 h sampling evidence_span: {"source_cache": "artifacts/zeaxanthin-research/15137922.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "6410a0f5d52cf32390f90f59a7b17d2340a889f888836129f8a93482ca055be0", "start_char": 0, "end_char": 1847, "text_sha256": "6410a0f5d52cf32390f90f59a7b17d2340a889f888836129f8a93482ca055be0"} [zeaxanthin-p15137922] Comparison of plasma responses in human subjects after the ingestion of 3R,3R'-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R'-zeaxanthin using chiral high-performance liquid chromatography. (2004). https://pubmed.ncbi.nlm.nih.gov/15137922/ DOI: 10.1079/bjn20041105
Complete structured claim and evidenceMonoesters were detected in cells and basolateral medium after dipalmitate exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- Some ester-linked pigment also crossed this model.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 678–689
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-ester-mono-product Monoesters were detected in cells and basolateral medium after dipalmitate exposure. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Some ester-linked pigment also crossed this model. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidence
Where it participates (unsigned role)
Free zeaxanthin increased ABCG5 protein expression in Caco-2 cells.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- The cell increased a transporter subunit; actual zeaxanthin efflux was not established.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 691–702
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-abcg5-expression Free zeaxanthin increased ABCG5 protein expression in Caco-2 cells. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cell increased a transporter subunit; actual zeaxanthin efflux was not established. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceJ-aggregated dipalmitate gave a 23% higher AUC estimate than H-aggregated free pigment, with P=0.064.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/29185931.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3db71b8dc1b111c999db31427237d2296afb9024060396a63b2b2bc4d9bbcd37", "start_char": 0, "end_char": 1785, "text_sha256": "3db71b8dc1b111c999db31427237d2296afb9024060396a63b2b2bc4d9bbcd37"}
- experimental_model
- Randomized two-way crossover and simulated digestion
- exposure
- 10 mg free-zeaxanthin equivalents in H-aggregated free or J-aggregated dipalmitate formulations
- limitations
- The 23% higher AUC estimate had P=0.064 and did not meet 0.05; aggregation and esterification changed together.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- 16 human participants and in vitro digestion
- plain_language
- The estimate favored one formulation, but statistical uncertainty remained.
- primary_references
- [zeaxanthin-p29185931] Effect of aggregation form on bioavailability of zeaxanthin in humans: a randomised cross-over study. (2017). https://pubmed.ncbi.nlm.nih.gov/29185931/ DOI: 10.1017/s0007114517002653
- tissue_or_cell_type
- TAG-rich lipoprotein response
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 821–832
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized two-way crossover and simulated digestion · source_derived_draft · unverified_draft
### zeaxanthin-aggregation-trend J-aggregated dipalmitate gave a 23% higher AUC estimate than H-aggregated free pigment, with P=0.064. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The estimate favored one formulation, but statistical uncertainty remained. organism: 16 human participants and in vitro digestion tissue_or_cell_type: TAG-rich lipoprotein response experimental_model: Randomized two-way crossover and simulated digestion limitations: The 23% higher AUC estimate had P=0.064 and did not meet 0.05; aggregation and esterification changed together. exposure: 10 mg free-zeaxanthin equivalents in H-aggregated free or J-aggregated dipalmitate formulations evidence_span: {"source_cache": "artifacts/zeaxanthin-research/29185931.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3db71b8dc1b111c999db31427237d2296afb9024060396a63b2b2bc4d9bbcd37", "start_char": 0, "end_char": 1785, "text_sha256": "3db71b8dc1b111c999db31427237d2296afb9024060396a63b2b2bc4d9bbcd37"} [zeaxanthin-p29185931] Effect of aggregation form on bioavailability of zeaxanthin in humans: a randomised cross-over study. (2017). https://pubmed.ncbi.nlm.nih.gov/29185931/ DOI: 10.1017/s0007114517002653
Complete structured claim and evidenceEzetimibe-sensitive uptake also supported NPC1L1 involvement after dipalmitate exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- The ester formulation also used the tested pathway.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 717–728
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-npc1l1-ester Ezetimibe-sensitive uptake also supported NPC1L1 involvement after dipalmitate exposure. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The ester formulation also used the tested pathway. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceEzetimibe-sensitive uptake supported NPC1L1 involvement in free-zeaxanthin uptake.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- The cholesterol-uptake pathway contributed in intestinal cells.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 639–650
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-npc1l1-uptake Ezetimibe-sensitive uptake supported NPC1L1 involvement in free-zeaxanthin uptake. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The cholesterol-uptake pathway contributed in intestinal cells. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceBLT-1-sensitive uptake supported SR-BI involvement after dipalmitate exposure.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- Esterification did not remove this transporter contribution.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 730–741
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-srbi-ester BLT-1-sensitive uptake supported SR-BI involvement after dipalmitate exposure. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Esterification did not remove this transporter contribution. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidenceBLT-1-sensitive uptake supported SR-BI involvement in free-zeaxanthin uptake.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"}
- experimental_model
- Micelle uptake, transporter inhibition and protein-expression assays
- exposure
- Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe
- limitations
- Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing.
- nutrient_topic
- Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. · Dietary (3R,3-prime-R)-zeaxanthin
- organism
- Human Caco-2 monolayers
- plain_language
- The shared carotenoid transporter contributed here too.
- primary_references
- [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
- tissue_or_cell_type
- Intestinal epithelial model
Zeaxanthin: metabolism, signaling and nutrient connections (2026-09-17) · lines 652–663
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Micelle uptake, transporter inhibition and protein-expression assays · source_derived_draft · unverified_draft
### zeaxanthin-srbi-intestinal BLT-1-sensitive uptake supported SR-BI involvement in free-zeaxanthin uptake. Condition category: normal nutrient_topic: Zeaxanthin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The shared carotenoid transporter contributed here too. organism: Human Caco-2 monolayers tissue_or_cell_type: Intestinal epithelial model experimental_model: Micelle uptake, transporter inhibition and protein-expression assays limitations: Inhibitors support pathway involvement rather than exclusivity. Protein-expression changes do not prove efflux; a cell model cannot establish clinical drug spacing. exposure: Free and dipalmitate xanthophyll micelles; BLT-1 and ezetimibe evidence_span: {"source_cache": "artifacts/zeaxanthin-research/42123990.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4", "start_char": 0, "end_char": 1803, "text_sha256": "c0b42011e7f16c3fe60d599d489d01e4b3098db9ad04856d26aca10008e995f4"} [zeaxanthin-p42123990] Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. (2026). https://pubmed.ncbi.nlm.nih.gov/42123990/ DOI: 10.3390/nu18091389
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.